OCU not enthusiastic about candidates for Patriarch of Bulgarian Church
OCU spokesperson Yevstratiy Zoria. Photo: Zoria's Facebook
On June 20, the Synod of the Bulgarian Orthodox Church, in 42 rounds of voting, shortlisted three candidates for the election of the Patriarch. OCU spokesperson Yevstratiy Zoria, who had high hopes for the new head of the BOC, evaluated each of them on his Facebook page.
"Metropolitan Grigoriy of Vratsa was elected locum tenens of the throne after the burial of the late Patriarch Neophyte. He appears to be a compromise figure," Zoria wrote.
The other two hierarchs, according to the OCU spokesperson, "are considered close to the old course" (presumably referring to the course of the late Patriarch Neophyte – Ed.).
As the UOJ reported, Yevstratiy Zoria stated that there had been some "positive shifts" between the Bulgarian Orthodox Church and his structure, and the responsibility for the final decision on recognizing the OCU will lie with the newly elected Primate of the BOC.
Read also
UOC Primate blesses special prayer rule for Great Lent
Metropolitan Onuphry blessed to pray for peace in Ukraine during Great Lent.
In Britain, Christians are no longer majority
According to a Pew Research Center study, the share of Christians in the United Kingdom has fallen below 50%.
His Beatitude Onuphry addresses flock before Great Lent
The Primate of the UOC blessed the faithful for the upcoming Great Lent.
Lavra Reserve complains to UNESCO about heating and power outage
International experts studied possible threats to the Kyiv-Pechersk Lavra – from missile strikes to power and heating outages.
Konotop Eparchy Administration is under repair after shelling
The replacement of the windows damaged as a result of the shelling in the Church of All Saints and the building of the Konotop Eparchy has become possible thanks to donations from believers.
Priests and laity of Rivne Eparchy donate blood for children with cancer
In Rivne, the UOC clergy and laity have donated blood for children undergoing treatment for cancer.